The US Food and Drug Administration has indicated that it plans to begin regulating laboratory-developed tests (LDTs) in order to assure the public that all in vitro diagnostic tests used in the provision of healthcare, whether developed by a laboratory or by other manufacturers, are safe and effective1,2...
Scrip Regulatory Affairs
US FDA indicates plans to regulate laboratory-developed tests
17 June 2010
Vibha Sharma
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
